메뉴 건너뛰기




Volumn 7, Issue 3, 2009, Pages 340-345

Long-term CD4 cell count recovery among Thai naive HIV-infected patients initiating HAART at low CD4 cell count

Author keywords

CD4 cell count recovery; Long term; Low and very low baseline CD4 cell count; Retrospective study

Indexed keywords

EFAVIRENZ; GPO VIR; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EID: 67649099431     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209788347903     Document Type: Review
Times cited : (6)

References (24)
  • 1
    • 0032576426 scopus 로고    scopus 로고
    • Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group
    • Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352: 1725-30.
    • (1998) Lancet , vol.352 , pp. 1725-1730
    • Mocroft, A.1    Vella, S.2    Benfield, T.L.3
  • 2
    • 2642709177 scopus 로고    scopus 로고
    • Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
    • Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl J Med 1998; 338: 853-60.
    • (1998) New Engl J Med , vol.338 , pp. 853-860
    • Palella Jr, F.J.1    Delaney, K.M.2    Moorman, A.C.3
  • 3
    • 10744227881 scopus 로고    scopus 로고
    • CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: The Swiss HIV Cohort Study
    • Kaufmann GR, Perrin L, Pantaleo G, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med 2003; 163: 2187-95.
    • (2003) Arch Intern Med , vol.163 , pp. 2187-2195
    • Kaufmann, G.R.1    Perrin, L.2    Pantaleo, G.3
  • 4
    • 33845396491 scopus 로고    scopus 로고
    • A comparison of three highly active antiretroviral treatment strategies consisting of nonnucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): A long-term randomised trial
    • MacArthur RD, Novak RM, Peng G, et al. A comparison of three highly active antiretroviral treatment strategies consisting of nonnucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial. Lancet 2006; 368: 2125-35.
    • (2006) Lancet , vol.368 , pp. 2125-2135
    • MacArthur, R.D.1    Novak, R.M.2    Peng, G.3
  • 5
    • 33846439783 scopus 로고    scopus 로고
    • CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression
    • Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis 2007; 44: 441-6.
    • (2007) Clin Infect Dis , vol.44 , pp. 441-446
    • Moore, R.D.1    Keruly, J.C.2
  • 6
    • 2542496096 scopus 로고    scopus 로고
    • Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
    • Garcia F, de Lazzari E, Plana M, et al. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr 2004; 36: 702-13.
    • (2004) J Acquir Immune Defic Syndr , vol.36 , pp. 702-713
    • Garcia, F.1    de Lazzari, E.2    Plana, M.3
  • 7
    • 0041326880 scopus 로고    scopus 로고
    • Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
    • Hunt PW, Deeks SG, Rodriguez B, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 2003; 17: 1907-15.
    • (2003) AIDS , vol.17 , pp. 1907-1915
    • Hunt, P.W.1    Deeks, S.G.2    Rodriguez, B.3
  • 8
    • 34547478269 scopus 로고    scopus 로고
    • Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: An observational cohort study
    • Mocroft A, Phillips AN, Gatell J, et al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007; 370: 407-13.
    • (2007) Lancet , vol.370 , pp. 407-413
    • Mocroft, A.1    Phillips, A.N.2    Gatell, J.3
  • 9
    • 0035362495 scopus 로고    scopus 로고
    • Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy
    • Tarwater PM, Margolick JB, Jin J, et al. Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 27: 168-75.
    • (2001) J Acquir Immune Defic Syndr , vol.27 , pp. 168-175
    • Tarwater, P.M.1    Margolick, J.B.2    Jin, J.3
  • 10
    • 37349126951 scopus 로고    scopus 로고
    • Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia
    • Ferradini L, Laureillard D, Prak N, et al. Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS 2007; 21: 2293-301.
    • (2007) AIDS , vol.21 , pp. 2293-2301
    • Ferradini, L.1    Laureillard, D.2    Prak, N.3
  • 11
    • 17144373731 scopus 로고    scopus 로고
    • Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: Evidence of extended virologic and CD4+ cell count responses
    • Kabugo C, Bahendeka S, Mwebaze R, et al. Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses. J Acquir Immune Defic Syndr 2005; 38: 78-94.
    • (2005) J Acquir Immune Defic Syndr , vol.38 , pp. 78-94
    • Kabugo, C.1    Bahendeka, S.2    Mwebaze, R.3
  • 12
    • 2142764446 scopus 로고    scopus 로고
    • Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
    • Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18: 887-95:
    • (2004) AIDS , vol.18 , pp. 887-895
    • Coetzee, D.1    Hildebrand, K.2    Boulle, A.3
  • 13
    • 33750253231 scopus 로고    scopus 로고
    • Globil and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
    • Hemelaar J, Gouws E, Ghys PD, Osmanov, S. Globil and regional distribution of HIV-1 genetic subtypes and recombinants in 2004 AIDS 2006; 20: W13-23.
    • (2006) AIDS , vol.20
    • Hemelaar, J.1    Gouws, E.2    Ghys, P.D.3    Osmanov, S.4
  • 14
    • 53349171968 scopus 로고    scopus 로고
    • CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
    • Khanna N, Opravil M, Furrer H, et al. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clin Infect Dis 2008; 47: 1093-101.
    • (2008) Clin Infect Dis , vol.47 , pp. 1093-1101
    • Khanna, N.1    Opravil, M.2    Furrer, H.3
  • 15
    • 0032771054 scopus 로고    scopus 로고
    • Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
    • Mezzaroma I, Carlesimo M, Pinter E, et al. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS 1999; 13: 1187-93.
    • (1999) AIDS , vol.13 , pp. 1187-1193
    • Mezzaroma, I.1    Carlesimo, M.2    Pinter, E.3
  • 16
    • 0030868897 scopus 로고    scopus 로고
    • Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
    • Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112-6.
    • (1997) Science , vol.277 , pp. 112-116
    • Autran, B.1    Carcelain, G.2    Li, T.S.3
  • 17
    • 34250335089 scopus 로고    scopus 로고
    • Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs
    • Le Moing V, Thiebaut R, Chene G, et al. Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs. HIV Med 2007; 8: 156-63.
    • (2007) HIV Med , vol.8 , pp. 156-163
    • Le Moing, V.1    Thiebaut, R.2    Chene, G.3
  • 18
    • 50949090165 scopus 로고    scopus 로고
    • Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases
    • Baker JV, Peng G, Rapkin J, et al. Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases. J Acquir Immune Defic Syndr 2008; 48: 541-6.
    • (2008) J Acquir Immune Defic Syndr , vol.48 , pp. 541-546
    • Baker, J.V.1    Peng, G.2    Rapkin, J.3
  • 19
    • 0032771054 scopus 로고    scopus 로고
    • Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
    • Mezzaroma I, Carlesimo M, Pinter E, et al. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS 1999; 13: 1187-93.
    • (1999) AIDS , vol.13 , pp. 1187-1193
    • Mezzaroma, I.1    Carlesimo, M.2    Pinter, E.3
  • 20
    • 33745877595 scopus 로고    scopus 로고
    • Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART
    • Aiuti F, Mezzaroma I. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev 2006; 8: 88-97.
    • (2006) AIDS Rev , vol.8 , pp. 88-97
    • Aiuti, F.1    Mezzaroma, I.2
  • 21
    • 33645775059 scopus 로고    scopus 로고
    • CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
    • Lawn SD, Myer L. Bekker LG, Wood R. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis 2006; 6: 59.
    • (2006) BMC Infect Dis , vol.6 , pp. 59
    • Lawn, S.D.1    Myer, L.2    Bekker, L.G.3    Wood, R.4
  • 22
    • 38949104111 scopus 로고    scopus 로고
    • European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV infected adults
    • Clumeck N, Pozniak A, Raffi F. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV infected adults. HIV Med 2008; 9: 65-71.
    • (2008) HIV Med , vol.9 , pp. 65-71
    • Clumeck, N.1    Pozniak, A.2    Raffi, F.3
  • 23
    • 48949097660 scopus 로고    scopus 로고
    • Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
    • Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300: 555-70.
    • (2008) JAMA , vol.300 , pp. 555-570
    • Hammer, S.M.1    Eron Jr, J.J.2    Reiss, P.3
  • 24
    • 68349125047 scopus 로고    scopus 로고
    • Cited January 31, 2009. Available from
    • Current situation analysis. Cited January 31, 2009. Available from http://www.unaids.org/en/CountryResponses/Countries/thailand.asp.
    • Current situation analysis


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.